TMFUltraLong

Sean Williams

A Fool since 2010, Sean specializes in the health care sector, but also has a penchant for mining, retail, technology, and small-cap stocks. You can follow him on twitter at @TMFUltraLong.

TMFUltraLong’s Activity

Today

NL

Article

TMFUltraLong published an article 1 hour ago

The 5 Best Used Cars for Teen Drivers

With a mixture of safety, reliability, fuel economy, and price, these five cars stand out as Consumer Reports' top picks for teen drivers.

Yesterday

NL

Article

TMFUltraLong published an article 5:25 PM

This 1 Figure Could Keep the Stock Market From Reaching New Highs

The S&P 500 has been practically unstoppable for more than five years, but this one figure could mark the end of the rally.

NL

Article

TMFUltraLong published an article 3:15 PM

This Week in Biotech: Diabetes Patients Chalk Up 2 Impressive Victories

Legal settlements and victories, an FDA approval, and two positive clinical results take center stage in this holiday-shortened week in the biotech sector.

NL

Article

TMFUltraLong published an article 2:05 PM

Meet the Company That's Changing the Multiple Sclerosis Treatment Landscape

With four multiple sclerosis therapies already approved, another under FDA review, and one more in mid-stage studies, this biopharmaceutical company is addressing this disease head on.

NL

Article

TMFUltraLong published an article 11:15 AM

Can You Guess Which Coffee Chain Has the Most Loyal Customers? You Might Be Surprised!

Starbucks has a cult-like following -- but does it also have the most loyal customers?

Fri Apr 18

NL

Article

TMFUltraLong published an article 12:20 PM

In Case You Missed It: GlaxoSmithKline Just Had a Phenomenal Week!

Marred by bribery claims, GlaxoSmithKline shareholders may not be aware of how impressive of a week the company had from a regulatory and clinical standpoint.

NL

Article

TMFUltraLong published an article 10:20 AM

1 Great Dividend You Can Buy Right Now

This "transformative" company has boosted its quarterly payout by 47% since 2007 and could be in line for hefty growth thanks to Obamacare.

NL

Article

TMFUltraLong published an article 9:05 AM

Statistically Speaking, This Is the Best Gold Miner

Taking into consideration cash costs per ounce, production growth, debt levels, and forward earnings, this is the best gold miner.

Thu Apr 17

NL

Article

TMFUltraLong published an article 5:15 PM

Why Sears Holdings, Triangle Petroleum, and SanDisk Are Today's 3 Best Stocks

The S&P 500 makes it a perfect four-for-four this week as Sears, Triangle Petroleum, and SanDisk lead all stocks to the upside.

NL

Article

TMFUltraLong published an article 4:25 PM

3 Stocks Near 52-Week Highs Worth Selling

Are these three stocks sells or belles? You be the judge!

NL

Article

TMFUltraLong published an article 1:05 PM

Obamacare and Medicare Reimbursement Cuts Weigh on UnitedHealth Group in Q1

Lower Medicare reimbursements and the implementation of the ACA lower UnitedHealth Group's EPS by nearly $0.35 in a challenging first quarter.

NL

Article

TMFUltraLong published an article 1:05 PM

If This Biotech Drops Much Further I'm Going to Buy It!

This biotech behemoth dipped by more than 20% recently despite a growth rate that could easily equal 25% over the next five years. Needless to say, if it drops any further I'm going to buy it!

NL

Article

TMFUltraLong published an article 12:00 AM

Why Galectin Therapeutics Inc. Shares Jumped

Galectin shares soar following the company's dosing of its first patient in a second phase 1 cohort. Here's what shareholders should really be watching.

Wed Apr 16

NL

Article

TMFUltraLong published an article 5:15 PM

Why Zogenix, ImmunoGen, and voxeljet Are Today's 3 Best Stocks

The Beige Book release and key economic data pumps up the S&P 500 while Zogenix, ImmunoGen, and voxeljet lead individual stocks to the upside.

NL

Article

TMFUltraLong published an article 5:03 PM

3 Stocks to Get on Your Watchlist

Gilead Sciences, Silver Wheaton, and Rite Aid are this week's must-watch stocks.

NL

Article

TMFUltraLong published an article 2:05 PM

Could This Small-Cap Biotech's Experimental Diabetes Drug Be a Game Changer?

This Texas-based biotech reported positive proof-of-concept results earlier this week and could be set to upend a number of big pharmaceutical companies if its experimental drug continues to deliver.

NL

Article

TMFUltraLong published an article 1:41 PM

Why Zogenix Inc. Shares Rocketed Higher

Zogenix's pain reliever Zohydro ER has more twists than an M. Night Shyamalan movie. Find out what has shareholders grinning ear-to-ear today.

NL

Article

TMFUltraLong published an article 1:12 PM

Why ImmunoGen Inc. Shares Took Flight

ImmunoGen shares bounce after receiving fresh coverage from Wall Street. Find out what shareholders should really be focused on following this new rating.

Tue Apr 15

NL

Article

TMFUltraLong published an article 5:15 PM

Why FX Energy, Conn's, and Twitter Are Today's 3 Best Stocks

Bullish CPI data sends the S&P 500 decisively higher as FX Energy, Conn's and Twitter soar by double digits.

NL

Article

TMFUltraLong published an article 1:58 PM

Why Versartis Inc. Shares Briefly Popped

Versartis shares jump following the end of its post-IPO quiet period. Here's what investors should really be focused on.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.96
Player Rank 29 out of 75542
Score 15029.91
Score Change Today 0
Accuracy 87.53%
Active Picks 111
Total Picks 506
Best Pick FAZ (+278.97)
Worst Pick PCYC (-2947.95)
Average Score per Pick 29.94
Charms Earned 15
Highest Rated Favorite TMFBabo
Go to TMFUltraLong’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 3
Recs Received 11
People who have rec'd these posts 11
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board CAPS Feedback
Very First Post Tickering....Just a heads up... (10/14/2010)
Percentage of Posts Rec'd 100.00 %
Show TMFUltraLong’s 10 Latest Posts